Cargando…

Equine degenerative myeloencephalopathy: prevalence, impact, and management

Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy is an inherited neurodegenerative disorder affecting many horse breeds. Clinical signs include a symmetric ataxia and an abnormal stance at rest, similar to cervical vertebral compressive myelopathy, equine protozoal myeloencephali...

Descripción completa

Detalles Bibliográficos
Autores principales: Burns, Erin N, Finno, Carrie J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135079/
https://www.ncbi.nlm.nih.gov/pubmed/30234005
http://dx.doi.org/10.2147/VMRR.S148542
_version_ 1783354778014711808
author Burns, Erin N
Finno, Carrie J
author_facet Burns, Erin N
Finno, Carrie J
author_sort Burns, Erin N
collection PubMed
description Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy is an inherited neurodegenerative disorder affecting many horse breeds. Clinical signs include a symmetric ataxia and an abnormal stance at rest, similar to cervical vertebral compressive myelopathy, equine protozoal myeloencephalitis, and equine herpesvirus 1 myeloencephalopathy. This review will provide an update on the disease prevalence, management, impact, and ongoing research.
format Online
Article
Text
id pubmed-6135079
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61350792018-09-19 Equine degenerative myeloencephalopathy: prevalence, impact, and management Burns, Erin N Finno, Carrie J Vet Med (Auckl) Review Equine neuroaxonal dystrophy/equine degenerative myeloencephalopathy is an inherited neurodegenerative disorder affecting many horse breeds. Clinical signs include a symmetric ataxia and an abnormal stance at rest, similar to cervical vertebral compressive myelopathy, equine protozoal myeloencephalitis, and equine herpesvirus 1 myeloencephalopathy. This review will provide an update on the disease prevalence, management, impact, and ongoing research. Dove Medical Press 2018-09-07 /pmc/articles/PMC6135079/ /pubmed/30234005 http://dx.doi.org/10.2147/VMRR.S148542 Text en © 2018 Burns and Finno. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Review
Burns, Erin N
Finno, Carrie J
Equine degenerative myeloencephalopathy: prevalence, impact, and management
title Equine degenerative myeloencephalopathy: prevalence, impact, and management
title_full Equine degenerative myeloencephalopathy: prevalence, impact, and management
title_fullStr Equine degenerative myeloencephalopathy: prevalence, impact, and management
title_full_unstemmed Equine degenerative myeloencephalopathy: prevalence, impact, and management
title_short Equine degenerative myeloencephalopathy: prevalence, impact, and management
title_sort equine degenerative myeloencephalopathy: prevalence, impact, and management
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6135079/
https://www.ncbi.nlm.nih.gov/pubmed/30234005
http://dx.doi.org/10.2147/VMRR.S148542
work_keys_str_mv AT burnserinn equinedegenerativemyeloencephalopathyprevalenceimpactandmanagement
AT finnocarriej equinedegenerativemyeloencephalopathyprevalenceimpactandmanagement